In cancer development, abnormal expression of RAB1A is involved in the progression of various cancers, such as colon cancer [32], tongue cancer [33], and glioma [34] in humans, all of which exhibit some degree of cancer-promoting effects in a gene dose-dependent manner. The gene discussed is RAB1A; the disease is central nervous system cancer.